COMMUNIQUÉS West-GlobeNewswire

-
Catalyst Biosciences Announces the Calling of Remaining Warrants and Conversion of Remaining Series A Preferred Shares Issued April 12, 2017
05/03/2018 -
Endocyte to Present at the Cowen and Company 38th Annual Health Care Conference
05/03/2018 -
Spring Bank Pharmaceuticals Appoints Timothy Clackson, Ph.D., to its Board of Directors
05/03/2018 -
Aduro Biotech Appoints Hans van Eenennaam Executive Vice President Antibody Research and Site Head, Aduro Biotech Europe
05/03/2018 -
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2018
05/03/2018 -
Maple Leaf Provides Update on its Telkwa, British Columbia Facility
05/03/2018 -
Cytokinetics to Present at March Investor Conferences
05/03/2018 -
Galectin Therapeutics Announces Record Date and Annual Stockholders Meeting Date for 2018
05/03/2018 -
OpGen Announces Date of Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call
05/03/2018 -
Kevin J. Dallas Joins Align Technology Board of Directors
05/03/2018 -
Obalon Announces Fourth Quarter and Full Year 2017 Financial Results
05/03/2018 -
New Opportunity Navigator™ Predictive Analytics Solution Refined Through Vital Images® and Fairview Collaboration
05/03/2018 -
Biodesix Raises Add-On to Series G, Enters into Debt Refinancing Agreement with Innovatus Capital Partners
05/03/2018 -
Notification about capital shares
05/03/2018 -
GW Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference on 12 March
05/03/2018 -
Healthwise and Mytonomy Partner to Deliver Health Education Videos
05/03/2018 -
Adaptimmune to Report Fourth Quarter / Full Year 2017 Financial Results and Business Update on Thursday March 15, 2018
05/03/2018 -
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2018
05/03/2018 -
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 28 février 2018
05/03/2018
Pages